These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32272196)

  • 1. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
    Dal Moro F; Livi U
    Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
    [No Abstract]   [Full Text] [Related]  

  • 2. The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?
    Dal Moro F; Vendramin I; Livi U
    Med Hypotheses; 2020 Oct; 143():110129. PubMed ID: 32721814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purposing Saikosaponins for the treatment of COVID-19.
    Bahbah EI; Negida A; Nabet MS
    Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposed use of thalidomide for the cytokine storm of COVID-19.
    Goihman-Yahr M
    Clin Dermatol; 2020; 38(4):508. PubMed ID: 32972614
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxytocin as a potential defence against Covid-19?
    Soumier A; Sirigu A
    Med Hypotheses; 2020 Jul; 140():109785. PubMed ID: 32344303
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 8. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
    Severa M; Farina C; Salvetti M; Coccia EM
    Front Immunol; 2020; 11():1459. PubMed ID: 32655578
    [No Abstract]   [Full Text] [Related]  

  • 9. The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
    Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S
    Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
    Cadegiani FA
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 13. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 16. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.
    Sodhi M; Etminan M
    Pharmacotherapy; 2020 May; 40(5):487-488. PubMed ID: 32267566
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
    Bou Khalil R
    Med Hypotheses; 2020 Sep; 142():109798. PubMed ID: 32413699
    [No Abstract]   [Full Text] [Related]  

  • 19. Colchicine may not be effective in COVID-19 infection; it may even be harmful?
    Cumhur Cure M; Kucuk A; Cure E
    Clin Rheumatol; 2020 Jul; 39(7):2101-2102. PubMed ID: 32394215
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.